Phase II clinical trial of didemnin B in previously treated small cell lung cancer

1994 ◽  
Vol 12 (3) ◽  
pp. 243-249 ◽  
Author(s):  
Dong M. Shin ◽  
Paul Y. Holoye ◽  
Arthur Forman ◽  
Rodger Winn ◽  
Roman Perez-Soler ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Didemnin B ◽  
Small Cell Lung ◽  
Previously Treated

A phase II clinical trial of the CDK 4/6 inhibitor palbociclib (PD 0332991) in previously treated, advanced non-small cell lung cancer (NSCLC) patients with inactivated CDKN2A.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 8077-8077 ◽  
Author(s):  
Priya Kadambi Gopalan ◽  
Mary Colleen Pinder ◽  
Alberto Chiappori ◽  
Alison Marguerite Ivey ◽  
Andres Gordillo Villegas ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Small Cell Lung ◽  
Previously Treated ◽  
Nsclc Patients

Phase II Clinical Trial of Lobaplatin (D-19466) in Pretreated Patients with Small-Cell Lung Cancer

1996 ◽  
Vol 19 (4) ◽  
pp. 328-332 ◽  
Author(s):  
H.H. Fiebig ◽  
H. Henß ◽  
I. von Pawel ◽  
U. Gatzemeier ◽  
Ch. Manegold ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Small Cell Lung ◽  
Pretreated Patients

A phase II clinical trial of gemcitabine and imatinib mesylate for patients with recurrent non-small cell lung cancer (NSCLC)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 19101-19101
Author(s):  
M. Eleff ◽  
M. A. Sovak ◽  
D. Greenberg ◽  
L. Guensch ◽  
P. Joyce ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Imatinib Mesylate ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document